𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome

✍ Scribed by Jens Michael Hertz; Inger Juncker; Ulf Persson; Gert Matthijs; Jörg Schmidtke; Michael B. Petersen; Margrethe Kjeldsen; Niels Gregersen


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
260 KB
Volume
18
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Alport syndrome is a progressive renal disease leading to chronic renal failure, which often is accompanied by sensorineural deafness and ophthalmological signs in the form of anterior lenticonus. The X-linked form of the disease is caused by mutations in the COL4A5 gene encoding the a5-chain of type IV-collagen. We performed mutation analysis of the COL4A5 gene by PCR-SSCP analysis of each of the 51 exons with flanking intronic sequences in 81 patients suspected of X-linked Alport syndrome including 29 clear X-linked cases, 37 cases from families with a pedigree compatible with X-linked inheritance, and 15 isolated cases. We found a mutation detection rate of 52% (42/81) (58% in males and 21% in females), and 69% (20/29) in families who clearly demonstrated X-linked inheritance. Thirty-six different mutations were found in 42 patients comprising 16 missense mutations, seven frameshifts, three in-frame deletions, four nonsense mutations, and six splice site mutations. Twenty-two of the mutations have not previously been reported. Furthermore, we found one non-pathogenic amino acid substitution, one rare variant in a noncoding region, and one polymorphism with a heterozygosity of 28%. Three de novo mutations were found, two of which were paternal and one of maternal origin. Hum Mutat 18:141-148, 2001.


📜 SIMILAR VOLUMES


Detection of mutations in COL4A5 in pati
✍ Kate E. Plant; Peter M. Green; David Vetrie; Frances A. Flinter 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB 👁 2 views

Alport syndrome (AS) can be caused by mutations in COL4A5, one of the six type IV collagen genes. For the purposes of confirming diagnoses, carrier screening and correlating genotype to phenotype, we have screened all 51 exons of this gene by SSCP analysis in 153 families with suspected AS. Mutation

A two-tier approach to mutation detectio
✍ Kathy King; Frances A. Flinter; Peter M. Green 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

About 85% of Alport syndrome is an X-linked semi-dominant condition caused by mutations in the collagen gene, COL4A5. The large size and high GC content of this gene have presented diagnostic laboratories with problems in identifying mutations with greater than about a 50% success rate since the gen

Spectrum of COL4A5 mutations in Finnish
✍ Paula Martin; Niina Heiskari; Heli Pajari; Carola Grönhagen-Riska; Helena Kääriä 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Alport syndrome (AS) is a hereditary kidney disorder, mainly caused by mutations in the Xchromosomal gene (COL4A5) encoding the type IV collagen α α5 chain. In this study, detection of COL4A5 mutations was performed in 17 Finnish Alport syndrome families. Regions around the 51 previously known exons

Deletion spanning the 5′ ends of both th
✍ Alessandra Renieri; Maria Teresa Bassi; Lucia Galli; Jing Zhou; Marisa Giani; Ma 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

## Communicated by Sesgio Otrdenghi Alport's syndrome is characterized clinically by a nonimmune glomerulopathy, often accompanied by sensorineural hearing loss and lens abnormalities, frequently due to mutations in the COL4A5 gene.